DUBLIN, Nov. 27, 2023 /PRNewswire/ — The “Glioma Treatment Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global glioma treatment market is expected to grow from $4.37 billion in 2022 to $4.70 billion in 2023 at a compound annual growth rate (CAGR) of 7.4%. The glioma treatment market is expected to reach $5.99 billion […]
/PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that.
Karyopharm Announces New Preliminary Data in Overall Survival (OS) in Selinexor-Treated Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer as Part of Pre-Specified Exploratory Subgr streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year price target among […]